Loomis, Sayles & Company’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-146,604
Closed -$10M 997
2022
Q1
$10M Sell
146,604
-3,629
-2% -$259K 0.01% 369
2021
Q4
$11.9M Sell
150,233
-1,392
-0.9% -$116K 0.01% 362
2021
Q3
$12M Sell
151,625
-47,867
-24% -$3.85M 0.01% 364
2021
Q2
$15.7M Sell
199,492
-36,581
-15% -$2.8M 0.02% 329
2021
Q1
$17.8M Sell
236,073
-7,731
-3% -$567K 0.02% 307
2020
Q4
$16M Sell
243,804
-16,471
-6% -$963K 0.02% 289
2020
Q3
$14M Buy
260,275
+24,730
+10% +$1.36M 0.02% 277
2020
Q2
$11.3M Buy
+235,545
New +$10.4M 0.02% 288

Other funds holding ENOV

Loomis, Sayles & Company's ENOV Position: Q2 2022 in Review

Loomis, Sayles & Company sold out of Enovis (ENOV) in Q2 2022, closing a stake of 146,604 shares — an estimated $10M sold.

Loomis, Sayles & Company first reported a position in ENOV in Q2 2020 and held it in 8 quarters. The position peaked at $17.8M in Q1 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

  • Loomis, Sayles & Company reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 146,604 Enovis shares in Q2 2022, an estimated $10M.
  • Loomis, Sayles & Company first reported a position in Enovis in Q2 2020 and held it in 8 quarters.
  • Loomis, Sayles & Company's Enovis position peaked at $17.8M in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Loomis, Sayles & Company's 13F filing for Q2 2022, filed 5 Aug 2022.